Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancer
Authors
Keywords
Low-dose gemcitabine, Major histocompatibility complex class 1-related chain A/B, γδ T cell, Pancreatic cancer, Chemotherapy
Journal
CLINICAL AND EXPERIMENTAL MEDICINE
Volume 17, Issue 1, Pages 19-31
Publisher
Springer Nature
Online
2015-10-08
DOI
10.1007/s10238-015-0394-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metastasis-promoting role of extravasated platelet activation in tumor
- (2015) Tomoharu Miyashita et al. JOURNAL OF SURGICAL RESEARCH
- Novel Bispecific Antibodies Increase T-Cell Cytotoxicity against Pancreatic Cancer Cells
- (2014) H.-H. Oberg et al. CANCER RESEARCH
- Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer
- (2014) Kousaku Mimura et al. INTERNATIONAL JOURNAL OF CANCER
- Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention
- (2014) Aroa Baragaño Raneros et al. OncoImmunology
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
- (2013) L Bracci et al. CELL DEATH AND DIFFERENTIATION
- Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17
- (2013) Guranda Chitadze et al. INTERNATIONAL JOURNAL OF CANCER
- ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells
- (2013) Chunning Zheng et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
- (2013) Matilde Todaro et al. OncoImmunology
- Role of Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Is Tumor Budding the Missing Link?
- (2013) Eva Karamitopoulou Frontiers in Oncology
- Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside
- (2012) Mounia S. Braza et al. BRITISH JOURNAL OF HAEMATOLOGY
- What lessons can be learned from γδ T cell-based cancer immunotherapy trials?
- (2012) Jean-Jacques Fournié et al. Cellular & Molecular Immunology
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Immunotherapy updates in pancreatic cancer: are we there yet?
- (2012) Krishna Soujanya Gunturu et al. Therapeutic Advances in Medical Oncology
- High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas
- (2011) M. R. Zocchi et al. BLOOD
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
- (2011) Myriam Labelle et al. CANCER CELL
- Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice
- (2011) B. L. Mundy-Bosse et al. CANCER RESEARCH
- Activation of epidermal growth factor receptor signaling by the prostaglandin E2 receptor EP4 pathway during gastric tumorigenesis
- (2011) Hiroko Oshima et al. CANCER SCIENCE
- Human Ovarian Tumor Cells Escape γδ T Cell Recognition Partly by Down Regulating Surface Expression of MICA and Limiting Cell Cycle Related Molecules
- (2011) Jingwei Lu et al. PLoS One
- Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010
- (2011) Chakshu Sharma WORLD JOURNAL OF GASTROENTEROLOGY
- TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells
- (2010) Masahide Ebi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis
- (2010) Sílvia Cufí et al. CELL CYCLE
- TGF-β in the pathogenesis and prevention of disease: a matter of aneurysmic proportions
- (2010) Harry C. Dietz JOURNAL OF CLINICAL INVESTIGATION
- HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells
- (2010) Susanne Schuler et al. Molecular Cancer
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
- (2009) W M Liu et al. BRITISH JOURNAL OF CANCER
- Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both?
- (2008) Karin E. de Visser CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-Associated MICA Is Shed by ADAM Proteases
- (2008) I. Waldhauer et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started